PortfoliosLab logoPortfoliosLab logo
GIC vs. HALO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GIC vs. HALO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global Industrial Company (GIC) and Halozyme Therapeutics, Inc. (HALO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GIC achieves a 11.00% return, which is significantly higher than HALO's 3.27% return. Over the past 10 years, GIC has underperformed HALO with an annualized return of 21.48%, while HALO has yielded a comparatively higher 22.84% annualized return.


GIC

1D
0.38%
1M
10.90%
YTD
11.00%
6M
8.19%
1Y
26.13%
3Y*
8.68%
5Y*
2.22%
10Y*
21.48%

HALO

1D
-1.74%
1M
3.55%
YTD
3.27%
6M
11.72%
1Y
28.75%
3Y*
27.10%
5Y*
10.19%
10Y*
22.84%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GIC vs. HALO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GIC
Global Industrial Company
11.00%22.45%-34.29%69.66%-41.04%18.77%62.74%7.69%-1.33%286.91%
HALO
Halozyme Therapeutics, Inc.
3.27%40.77%29.36%-35.04%41.51%-5.85%140.89%21.19%-27.79%105.06%

Correlation

The correlation between GIC and HALO is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.21

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Mar 16, 2004

0.27

Fundamentals

Market Cap

GIC:

$1.22B

HALO:

$8.54B

EPS

GIC:

$1.96

HALO:

$2.87

PE Ratio

GIC:

16.28

HALO:

24.26

PEG Ratio

GIC:

15.54

HALO:

2.74

PS Ratio

GIC:

0.87

HALO:

5.61

PB Ratio

GIC:

2.10

HALO:

38.88

Total Revenue (TTM)

GIC:

$1.41B

HALO:

$1.51B

Gross Profit (TTM)

GIC:

$500.00M

HALO:

$1.23B

EBITDA (TTM)

GIC:

$106.30M

HALO:

$980.05M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GIC vs. HALO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GIC
GIC Risk / Return Rank: 6161
Overall Rank
GIC Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
GIC Sortino Ratio Rank: 6060
Sortino Ratio Rank
GIC Omega Ratio Rank: 6666
Omega Ratio Rank
GIC Calmar Ratio Rank: 5959
Calmar Ratio Rank
GIC Martin Ratio Rank: 5858
Martin Ratio Rank

HALO
HALO Risk / Return Rank: 6666
Overall Rank
HALO Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
HALO Sortino Ratio Rank: 6666
Sortino Ratio Rank
HALO Omega Ratio Rank: 6464
Omega Ratio Rank
HALO Calmar Ratio Rank: 6666
Calmar Ratio Rank
HALO Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GIC vs. HALO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global Industrial Company (GIC) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GICHALODifference
Sharpe ratioReturn per unit of total volatility

-0.36

Sortino ratioReturn per unit of downside risk

-0.27

Omega ratioGain probability vs. loss probability

1.19

1.17

+0.02

Calmar ratioReturn relative to maximum drawdown

0.76

1.14

-0.38

Martin ratioReturn relative to average drawdown

1.42

2.16

-0.74

GIC vs. HALO - Sharpe Ratio Comparison

The current GIC Sharpe Ratio is 0.55, which is lower than the HALO Sharpe Ratio of 0.91. The chart below compares the historical Sharpe Ratios of GIC and HALO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GIC vs. HALO - Drawdown Comparison

The maximum GIC drawdown since its inception was -98.09%, which is greater than HALO's maximum drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for GIC and HALO.


Loading charts...

Drawdown Indicators


GICHALODifference

Max Drawdown

Largest peak-to-trough decline

-98.09%

-74.26%

-23.83%

Max Drawdown (1Y)

Largest decline over 1 year

-30.04%

-24.13%

-5.91%

Max Drawdown (3Y)

Largest decline over 3 years

-53.19%

-33.92%

-19.27%

Max Drawdown (5Y)

Largest decline over 5 years

-53.19%

-49.06%

-4.13%

Max Drawdown (10Y)

Largest decline over 10 years

-55.74%

-49.06%

-6.68%

Current Drawdown

Current decline from peak

-25.96%

-14.44%

-11.52%

Average Drawdown

Average peak-to-trough decline

-58.91%

-31.88%

-27.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.02%

12.73%

+3.29%

Volatility

GIC vs. HALO - Volatility Comparison

The current volatility for Global Industrial Company (GIC) is 4.33%, while Halozyme Therapeutics, Inc. (HALO) has a volatility of 8.94%. This indicates that GIC experiences smaller price fluctuations and is considered to be less risky than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GICHALODifference

Volatility (1M)

Calculated over the trailing 1-month period

4.33%

8.94%

-4.61%

Volatility (6M)

Calculated over the trailing 6-month period

20.62%

24.02%

-3.40%

Volatility (1Y)

Calculated over the trailing 1-year period

41.31%

30.20%

+11.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.21%

39.42%

-0.21%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

46.36%

42.88%

+3.48%

Dividends

GIC vs. HALO - Dividend Comparison

GIC's dividend yield for the trailing twelve months is around 3.39%, while HALO has not paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
GIC
Global Industrial Company
3.39%3.56%4.03%2.06%3.06%4.01%9.92%1.91%39.51%1.05%1.14%
HALO
Halozyme Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

GIC vs. HALO - Financials Comparison

This section allows you to compare key financial metrics between Global Industrial Company and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M20222023202420252026
350.40M
376.71M
(GIC) Total Revenue
(HALO) Total Revenue
Values in USD except per share items

GIC vs. HALO - Profitability Comparison

The chart below illustrates the profitability comparison between Global Industrial Company and Halozyme Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
34.8%
79.0%
Portfolio components
GIC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Global Industrial Company reported a gross profit of 121.90M and revenue of 350.40M. Therefore, the gross margin over that period was 34.8%.

HALO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Halozyme Therapeutics, Inc. reported a gross profit of 297.47M and revenue of 376.71M. Therefore, the gross margin over that period was 79.0%.

GIC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Global Industrial Company reported an operating income of 20.60M and revenue of 350.40M, resulting in an operating margin of 5.9%.

HALO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Halozyme Therapeutics, Inc. reported an operating income of 184.52M and revenue of 376.71M, resulting in an operating margin of 49.0%.

GIC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Global Industrial Company reported a net income of 16.60M and revenue of 350.40M, resulting in a net margin of 4.7%.

HALO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Halozyme Therapeutics, Inc. reported a net income of 150.05M and revenue of 376.71M, resulting in a net margin of 39.8%.


Frequently Asked Questions


GIC and HALO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HALO has higher volatility (8.94%) compared to GIC (4.33%). In terms of maximum drawdown, GIC dropped -98.09% vs HALO's -74.26%.

HALO currently has the higher Sharpe Ratio (0.91 vs 0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GIC and HALO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer